Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

ICSI no more effective than IVF

26 January 2015

By Dr Kimberley Bryon-Dodd

Appeared in BioNews 787

A US study has found that despite increased use of intracytoplasmic sperm injection (ICSI) over recent years, the technique is not associated with any improved reproductive outcomes over conventional IVF.

The findings, published in JAMA, also indicated that ICSI might even have a detrimental effect in cases without male infertility.

ICSI is an adaptation of IVF, introduced in 1992, in which a single sperm is injected directly into the egg, which was developed primarily for use in cases of male infertility, such as low sperm count or poor sperm motility.

Using data from the US National Assisted Reproductive Technology Surveillance System, the researchers found that between 1996 and 2012, the incidence of ICSI during fresh IVF cycles more than doubled from 36.4 percent to 76.2 percent. The greatest increase was in cycles with no male infertility where ICSI use rose from 15.4 to 66.9 percent .

Using data for the 2008 to 2012 period, the researchers indirectly estimated fertilisation rates by looking at the number of cycles cancelled following oocyte retrieval. This indicated that, when male infertility was present, ICSI led to an increased likelihood of fertilisation compared with conventional IVF. But they also found that the reproductive outcomes - including pregnancy, miscarriage and live birth - of traditional IVF and IVF using ICSI were similar in cycles with male factor infertility.

Furthermore, in cycles without male factor infertility, the use of ICSI resulted in 'small but significant' reductions in implantation, pregnancy, live birth, multiple live birth and low birth weight rates compared with conventional IVF.

The researchers from the Centers for Disease Control and Prevention in Atlanta comment: 'Although such differences may be a function of the large sample size and thus not clinically relevant, our findings suggest that use of ICSI may improve fertilisation rates but not implantation or pregnancy rates in the setting of unexplained infertility, advanced maternal age, and low oocyte yield.'

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

10 October 2016 - by Rikita Patel 
The first generation of men born through intracytoplasmic sperm injection (ICSI) have lower sperm counts, according to a small study...
06 June 2016 - by Professor Susan Bewley 
As a long-time obstetric ringside observer, it seems to me that unnecessary and expensive treatments are de rigeur in the fertility industry, something that's haunted the field for decades...
31 May 2016 - by Sarah Gregory 
The editor-in-chief of Human Reproduction has criticised the overuse of ICSI, following a world report into the use of assisted reproduction technologies...
18 January 2016 - by Ayala Ochert 
Scientists in Germany have created artificially motorised sperm, propelled by microscopic metal helices...
28 September 2015 - by Arit Udoh 
A study shows that treatment of unexplained infertility with the standard treatment clomiphene results in more live births, and a lower risk of multiple births, than a potential new drug letrozole...

11 November 2013 - by Dr Steven Fleming 
Despite the views of several IVF experts that intra-cytoplasmic sperm injection is overused in IVF, it continues unabated. So why is nobody listening?...
09 July 2008 - by Ailsa Stevens 
BioNews reporting from ESHRE, Barcelona:By Ailsa Taylor:Data presented at the annual conference of the European Society of Human Reproduction and Embryology (ESHRE) shows that the number of cycles carried out annually in Europe has more than doubled since records began in 1997, when 200,000 cycles were carried out...
23 July 2007 - by Dr Jess Buxton 
An assisted reproduction technique used to overcome male infertility is increasingly being used to treat couples who may not need it, say US researchers. Dr Tarun Jain and his colleagues, based at the University of Illinois at Chicago, say that the use of intracytoplasmic sperm injection...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation